Internal combustion engine vehicles remain the dominant next-purchase option, while hybrids are emerging as the preferred transition technology. A new study from Deloitte India indicates that 95 per ...

Defence Holdings PLC (LSE: ALRT), the UK’s listed software-led defence technology company, today announces the launch of the Defence Holdings Accelerator, a structured programme designed to identify, ...

Donnelley Financial Solutions recently reported quarterly results that exceeded analysts’ revenue and EPS estimates despite a year-on-year revenue decline and cautious guidance on capital ...

NI, a part of Emerson, has long provided software tools for electronics test and measurement. The company’s LabVIEW software is a graphical programming platform extensively used for data acquisition ...

Feb 10 (Reuters) - Concerns that artificial intelligence could disrupt large parts of the software industry have started to spill into credit markets, Morgan Stanley warned, as software accounts for ...

Wall Street has been skeptical about software stocks in recent times, but a phase of outright panic hit this week. Traders are dumping shares across the sector as fears mount that artificial ...

IT stocks globally have been under pressure for months, due to fears of AI affecting future business growth. The latest crash in prices comes on the back of Anthropic rolling out new legal tools for ...

Software shares plunged on Thursday, even after some of the biggest names in the industry reported positive earnings. Microsoft (MSFT) was at the forefront of the trend, with the stock dropping ...

Arvind Krishna, CEO, President & Chairman, highlighted that "we are excited about the progress we made in 2025, delivering 6% revenue growth, our highest level of revenue growth in many years and ...

Workday CEO Carl Eschenbach called concerns that artificial intelligence is destroying software "overblown" on CNBC's "Squawk Box." The boom in AI models that can write code cheaper and quicker has ...

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...